Biotech Company Secures Canadian Patent Covering NKT Cell Modulators: Revolutionary Cancer Treatment

GRI Bio Secures Canadian Patent for Advanced Natural Killer T Cell Modulators: A Leap Forward in Cancer Immunotherapy.

Disclaimer: This post contains information about GRI Bio, a leading biotech company. The author has no affiliation with GRI Bio or any financial interest in the company.

GRI Bio, a prominent player in the biotechnology sector, recently announced the allowance of a significant patent in Canada. The patent covers their proprietary Natural Killer T (NKT) Ce…